- Title
- Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial
- Creators - without role
- G. Lavigne-Lissalde - Centre Hospitalier Universitaire de NîmesA.G. Aya - Centre Hospitalier Universitaire de NîmesF.J. Mercier - Hôpital Antoine-BéclèreS. Roger-Christoph - Clinique Les FontainesC. Chauleur - Centre Hospitalier Universitaire de Saint-ÉtienneE. Morau - Centre Hospitalier Universitaire de MontpellierA.S. Ducloy-Bouthors - Centre Hospitalier Régional Universitaire [CHU Lille]A. Mignon - Unité de Soins Intensifs [CHU Cochin]M. Raucoules - Centre Hospitalier Universitaire de NiceA. Bongain - Centre Hospitalier Universitaire de NiceF. Boehlen - University Hospital of GenevaP. de Moerloose - University Hospital of GenevaS. Bouvet - CegedimP. Fabbro-Peray - CegedimJean-Christophe Gris - Centre Hospitalier Universitaire de Nîmes
- Publication Details
- Journal of Thrombosis and Haemostasis, Vol.13(4), pp.520 - 529
- Identifiers
- 9944631309311
- Academic Unit
- Initial MAnagement & prevent of acute orGan failures IN critically ill patiEnts - IMAGINE
- Language
- English
- Resource Type
- Journal article
- Local Fields
- hal-01938275
Journal article
Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial
Journal of Thrombosis and Haemostasis, Vol.13(4), pp.520 - 529
04/2015
PMID: 25594352
Metrics
1 Record Views